HealthIT Answers December 20, 2022
CRISPR is a gene-editing technology that enables scientists to chemically snip out and rearrange genetic sequences to alter DNA, often with the goal of eliminating hereditary diseases. The technology holds enormous implications for our ability to treat and manage various life-threatening diseases, including many types of cancer.
In many respects, CRISPR can be a helpful analogy for considering how the healthcare industry might collaborate to improve the revenue cycle management (RCM) process. For example, if we think of the revenue cycle as the genome of the health system’s administrative operations and carry that analogy further, it unlocks a lot of interesting thought work about how to apply “CRISPR-like” technology in the revenue cycle.
If we equate the RCM processes, policies,...
Today's Sponsors
Today's Sponsor